multiple-myeloma

Documents about multiple-myeloma

• Identification of exhausted CD8(+) T-cell signatures for prognosis in multiple myeloma by integrated analysis of single-cell and bulk RNA-sequencing.#368076NCBI PubMed Central
• Emerging precision medicine in multiple myeloma: clinical and preclinical landscape of T cell, natural killer cell, and macrophages engaging multi-specific antibodies.#392775NCBI PubMed Central
• An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers#812988ClinicalTrials.gov
• Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients#830508ClinicalTrials.gov
• Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients#852672ClinicalTrials.gov
• Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy#894319ClinicalTrials.gov
• A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities#900174ClinicalTrials.gov
• Post-Op Pain Control for Prophylactic Intramedullary Nailing.#914629ClinicalTrials.gov
• Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols#201759ClinicalTrials.gov
• Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease#834808ClinicalTrials.gov
• Vertebral Augmentation With Kyphoplasty vs Nonsurgical Mgmt for Vertebral Body Compression Fractures#906253ClinicalTrials.gov
• Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients#909629ClinicalTrials.gov
• Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer#969513ClinicalTrials.gov
• In Vitro Drug Sensitivity Testing of Fresh Human Samples#981308ClinicalTrials.gov
• Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation#811961ClinicalTrials.gov
• Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib#905097ClinicalTrials.gov
• Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide#810245ClinicalTrials.gov
• Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid#832246ClinicalTrials.gov
• COVID19-hematological Malignancies: the Italian Hematology Alliance#834692ClinicalTrials.gov
• Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)#848723ClinicalTrials.gov
• Exercise During Chemotherapy for Patients With Hematological Malignancies#876014ClinicalTrials.gov
• Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection#901820ClinicalTrials.gov
• Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies#913238ClinicalTrials.gov
• Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen#993073ClinicalTrials.gov
• Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer#836349ClinicalTrials.gov
• Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma#296803Gestión del Repositorio Documental de la Universidad de Salamanca
• Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood#426768ClinicalTrials.gov
• Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy#868219ClinicalTrials.gov
• Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma#894700ClinicalTrials.gov
• Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)#899585ClinicalTrials.gov
• Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden#901363ClinicalTrials.gov
• Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss#907438ClinicalTrials.gov
• Tumor Registry of Lymphatic Neoplasia#912541ClinicalTrials.gov
• Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.#912766ClinicalTrials.gov
• Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival#294459Gestión del Repositorio Documental de la Universidad de Salamanca
• Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial#296801Gestión del Repositorio Documental de la Universidad de Salamanca
• Multiple Myeloma Risk Linked to DNA Damage Response Genes#295933Scholar Commons
• Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial#314320ClinicalTrials.gov
• Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention#356477ClinicalTrials.gov
• Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants#417539ClinicalTrials.gov
• Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study#846459ClinicalTrials.gov
• Pre-malignant States to Hematologic Malignancies in Firefighters#879352ClinicalTrials.gov
• Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)#811960ClinicalTrials.gov
• Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H#839460ClinicalTrials.gov
• A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.#842190ClinicalTrials.gov
• Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation#908269ClinicalTrials.gov
• <b>Curriculum Vitae – Professor Salah Eddine Belakehal, MD | Senior Hematologist, Hospital Executive and Clinical Research Leader</b>#220412Figshare
• National Longitudinal Cohort of Hematological Diseases#806657ClinicalTrials.gov
• NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma#802981ClinicalTrials.gov
• COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies#838735ClinicalTrials.gov